Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
diagnostics
3
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
3
×
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
bristol-myers squibb
cancer
cell therapy
clinical trials
immunotherapy
medicare
merck
nivolumab
novartis
pembrolizumab keytruda
abbvie
abeona therapeutics
What
new
3
×
bio
drug
roundup
advantages
approval
bar
biogen’s
biopharmaceutical
brings
cancer
centers
companies
convo
cut
depression
earlier
event
expect
failures
gamble
genetic
guesswork
guide
helps
littered
major
making
market
medco’s
medical
medicine
mover
nash
news
patients
payers
physicians
plan
practice
Language
unset
Current search:
diagnostics
×
new
×
" san francisco blog main "
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Will New Study Cut Guesswork for Depression Medicine Prescriptions?